28 note to investors, William Blair analysts wrote that Applied Therapeutics suspects the CRL was related to the efficacy package as opposed to [chemistry, manufacturing and controls] or safety. Results from the Phase III ACTION-Galactosemia Kids study, unveiled in April 2023, showed that govorestat fell short of its primary efficacy endpoint, a composite of four clinical measures designed to assess various domains of galactosemia symptoms
Raw peptide ingredients are relatively inexpensive
Licensing and certifications for dermal fillers and other cosmetic treatments can be really confusing, so well break down the details in a separate blog, but the answer is yes, our physician injectors are licensed to perform dermal filler injections, and they each have several years of experience doing so
T., Yanik K
Neshani et al
Studies demonstrate the peptide reduces markers of oxidative damage including lipid peroxidation and protein oxidation in brain tissue, suggesting antioxidant mechanisms that could protect neurons from stress-related damage
